General
A section of Vaccines (ISSN 2076-393X).
Section Information
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Current Development of Vaccines for Respiratory Viral Infection (Deadline: 31 May 2024)
- New Trends in Use of Animal Models in Vaccine Development (Deadline: 31 May 2024)
- Inequality in Immunization 2024 (Deadline: 15 June 2024)
- Synthetic Vaccines (Deadline: 21 June 2024)
- Immune Response in the Efficacy of Vaccines (Deadline: 30 June 2024)
- Next-Generation Vaccine and Immunotherapy (Deadline: 30 June 2024)
- Vaccines and Vaccination: Feature Papers (Deadline: 30 June 2024)
- Promoting Vaccination in the Post-COVID-19 Era (Deadline: 30 June 2024)
- Nanoparticle Based Vaccines (Deadline: 30 June 2024)
- Multiepitope Vaccines against Neglected, Emerging, and Re-emerging Global Diseases (Deadline: 30 June 2024)
- Immune Strategies and Vaccine Development against Veterinary Virus Infection (Deadline: 30 June 2024)
- Therapeutic Strategies Affecting MAPK-Oriented Interventions in Cancer (Deadline: 12 July 2024)
- Allergic Reactions to Currently Available COVID-19 Vaccination (Deadline: 31 July 2024)
- Vaccination and Treatments against Viral Hepatitis: Achievements, Challenges and Perspectives (Deadline: 31 July 2024)
- Cellular Immune Responses to Infectious Diseases (Deadline: 31 July 2024)
- The Role of Vaccination on Vaccine Preventable Foodborne Disease (Deadline: 31 July 2024)
- Safety and Immune Responses of Vaccines (Deadline: 31 July 2024)
- Vaccine Strategies for HPV-Related Cancers (Deadline: 31 July 2024)
- Neutralizing Antibodies against SARS-CoV-2 and HIV (Deadline: 1 August 2024)
- Extracellular Vesicles as a Platform for Vaccines (Deadline: 26 August 2024)
- The Role of B Cells and Antibodies against Infectious Diseases (Deadline: 31 August 2024)
- Research Progress of New Tuberculosis Vaccines and Vaccine Design (Deadline: 31 August 2024)
- Advances in Oral Vaccine Development (Deadline: 31 August 2024)
- Vaccine Adjuvants Targeting Emerging and Re-emerging Livestock Infectious Disease: Boosting Stronger Immune Responses (Deadline: 31 August 2024)
- The Effect of Influenza Vaccination on Chronic Disease (Deadline: 31 August 2024)
- Antiviral T and B Cell Immunity (Deadline: 15 September 2024)
- Recent Scientific Advances in Vaccine Platforms (Deadline: 30 September 2024)
- Vaccinal Antibodies: Immunological Methods to Induce Antibody Response (Deadline: 30 September 2024)
- Cancer Immunotherapy in the COVID-19 Pandemic Era (Deadline: 1 October 2024)
- Recent Advances in Malaria Vaccine Development (Deadline: 15 October 2024)
- Novel Vaccines and Vaccine Technologies for Emerging Infections (Deadline: 15 October 2024)
- Human Papillomavirus Vaccine against Cervical Cancer: New Usage Strategies and Coverage Issues (Deadline: 20 October 2024)
- Advances in Human Monkeypox Vaccines Effectiveness, Safety and Hesitancy (Deadline: 20 October 2024)
- Current Advances in mRNA Vaccines for Infectious Diseases and Cancer Immunotherapy (Deadline: 21 October 2024)
- The Current Development of Glycoconjugate Vaccines for Infectious Diseases (Deadline: 31 October 2024)
- Advancing the Science on Vaccine Hesitancy to Inform Interventions (Deadline: 31 October 2024)
- Recent Scientific Advances in Vaccines for Shigella (Deadline: 31 October 2024)
- 50 Years of Immunization—Steps Forward (Deadline: 31 October 2024)
- Strategies of Viral Vectors for Vaccine Development (Deadline: 31 October 2024)
- 2nd Edition: Safety and Autoimmune Response to SARS-CoV-2 Vaccination (Deadline: 31 October 2024)
- State-of-the-Art Vaccine Researches (Deadline: 1 November 2024)
- Clinical Strategies to Improve Efficacy, Effectiveness, and Safety of Vaccination in Humans (Deadline: 12 November 2024)
- Human Leukocyte Antigen (HLA)—Antigen Interactions in Vaccine Development (Deadline: 12 November 2024)
- Biotechnologies Applied in Vaccine Research (Deadline: 20 November 2024)
- Humoral and Cellular Response after Vaccination (Deadline: 30 November 2024)
- Maternal Vaccination and Vaccines (Deadline: 30 November 2024)
- Impact of Vaccines and Vaccination on the Gut Microbiota (Deadline: 30 November 2024)
- Novel HIV Immunization Regimens and Immune Implications (Deadline: 30 November 2024)
- Tuberculosis Vaccines and Host-Directed Therapies (Deadline: 30 November 2024)
- Maternal and Infant Immunity: Current Trends in Vaccinology (Deadline: 30 November 2024)
- Parasitic Infections: Therapy for Host Immunity and Vaccination (Deadline: 30 November 2024)
- The Effectiveness of Pneumococcal Conjugate Vaccines (Deadline: 30 November 2024)
- Vaccines against HIV and Other Viruses (Deadline: 30 November 2024)
- Innovations in Vaccine Technology (Deadline: 30 November 2024)
- Development of Vaccines against Bacterial Infections (Deadline: 30 November 2024)
- Role of Next Generation Vaccines in Immunotherapeutics (Deadline: 30 November 2024)
- 2nd Edition of Antibody Response to Infection and Vaccination (Deadline: 30 November 2024)
- Vaccines and Vaccinations in the Pandemic Period (Deadline: 15 December 2024)
- Human Cytomegalovirus Vaccine Development: Progress and Prospects (Deadline: 31 December 2024)
- New Approaches to Vaccine Development and Delivery (Deadline: 31 December 2024)
- Vaccine Uptake in Italy, through the OBVIOUS Project and Other Independent Research (Deadline: 31 December 2024)
- Promoting Research, Development and Access to Vaccines to Address Global Inequities (Deadline: 31 December 2024)
- Role of Vaccination on Epidemic Control of the Infectious Diseases and Impact on Public Health (Deadline: 31 December 2024)
- COVID-19 Vaccination and Public Health: Addressing Global, Regional and Within-Country Inequalities (Deadline: 31 December 2024)
- Novel Viral Vaccine and Molecular Immunology (Deadline: 31 December 2024)
- Advances in Glycoconjugate Vaccines and Nanovaccines (Deadline: 31 December 2024)
- Host–Virus Interactions and Vaccine Development (Deadline: 31 December 2024)
- Varicella and Zoster Vaccination (Deadline: 31 January 2025)
- Immune Responses to Vaccines in Patients with Hematologic Diseases (Deadline: 31 January 2025)
- Utilization of Non-human Viruses as Recombinant Vector Vaccines against Newly Emerging Human Viral Diseases (Deadline: 31 January 2025)
- Vaccination: Feature Review Papers (Deadline: 31 January 2025)
- Pharmacoepidemiology in Vaccine Safety and Efficacy (Deadline: 31 January 2025)
- Recent Scientific Development of Poliovirus Vaccines (Deadline: 31 January 2025)
- Antibody Immunity against Emerging Pathogens (Deadline: 31 January 2025)
- Studies on Viral Epitopes on Vaccine Particles to Inform Vaccine Development (Deadline: 15 February 2025)
- Vaccines Based on Dendritic Cells: Breaking Barriers to New Immune Response Approach (Deadline: 20 February 2025)
- Fish Disease Occurrence and Immune Prevention and Control (Deadline: 28 February 2025)
- Genome Analysis for Vaccines and Vaccination (Deadline: 31 March 2025)
- The Current Development of Flavivirus Vaccines, Diseases Control and Epidemiological Situation (Deadline: 31 March 2025)
- Exploring Cutaneous Autoimmune Disease Flares in the Wake of COVID-19 Infection and Vaccination (Deadline: 10 May 2025)
- Social Determinants on Attitudes Towards Vaccine (Deadline: 8 July 2025)
Topical Collection
Following topical collection within this section is currently open for submissions: